Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Obese patients may be undertreated
July 7th, 2005
Overweight and obese women with breast cancer may receive reduced doses of chemotherapy drugs, which may put them at greater risk of cancer recurrence, suggests a University of Rochester, New York, study. Women who are 20-25% over their ideal body weight have a 1.3 times greater risk of a recurrence of breast cancer, research indicates. Differences in body chemistry in overweight and obese women, including differences in estrogen and insulin levels, may account for their poorer prognosis. But, suggest the authors of the new study, there is evidence that inadequate doses of adjuvant chemotherapy may also contribute to the differences in outcome. Adjuvant chemotherapy is...
Source: Women's Health Weekly (2005-07-07)
|
